SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis
Ganggang Wang(Yantai University), Xiaoliang Wang(South China Agricultural University)
Cited by 6
Related Papers
Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
|Nature Communications|2022|154
Publisher Correction: Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma
|Nature Communications|2022|21
AMPK/PGC-1α and p53 modulate VDAC1 expression mediated by reduced ATP level and metabolic oxidative stress in neuronal cells
|Acta Biochimica et Biophysica Sinica|2024|12